Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population

References

• Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631–44
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
   PubMed Web of Science ®Google Scholar
• Lam C, Lim KH, Karumanchi SA. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005;46:1077–85
   PubMed Web of Science ®Google Scholar
• Kinzler WL, Vintzileos AM. Fetal growth restriction: a modern approach. Curr Opin Obstet Gynecol 2008;20:125–31
   PubMed Web of Science ®Google Scholar
• Lapaire O, Shennan A, Stepan H. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol 2010;151:122–9
   PubMed Web of Science ®Google Scholar
• De Vivo A, Baviera G, Giordano D, et al. Endoglin, PLGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand 2008;87:837–42
   PubMed Web of Science ®Google Scholar
• Hertig A, Berkane N, Lefevre G. Maternal serum sFlt-1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 2004;50:1702–3
   PubMed Web of Science ®Google Scholar
• McKeeman GC, Ardill JE, Caldwell CM, et al. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 2004;191:1240–6
   PubMed Web of Science ®Google Scholar
• Taylor RN, Grimwood J, Taylor RS, et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003;188:177–82
   PubMed Web of Science ®Google Scholar
• Tjoa ML, van Vugt JM, Mulders MA, et al. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 2001;98:600–7
   PubMed Web of Science ®Google Scholar
• Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PLGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010;202:161e1–11
   Web of Science ®Google Scholar
• Gómez O, Martínez JM, Figueras F, et al. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol 2005;26:490–4
   PubMed Web of Science ®Google Scholar
• Albaiges G, Missfelder-Lobos H, Lees C, et al. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks’ gestation. Obstet Gynecol 2000;96:559–64
   PubMed Web of Science ®Google Scholar
• Bower S, Bewley S, Campbell S. Improved prediction of preeclampsia by two stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993;82:78–83
   PubMed Web of Science ®Google Scholar
• Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. JAHA 2007;49:818–24
   Google Scholar
• Diab AE, El-Behery MM, Ebrahiem MA, Shehata AE. Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 2008;102:146–51
   PubMed Web of Science ®Google Scholar
• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130–7
   PubMed Web of Science ®Google Scholar
• Escudero C, Calle A. Hierro, oxígeno y desarrollo placentario en la génesis de la preeclampsia. Efectos de la altura en Ecuador. Rev Méd Chile 2006;134:491–8
   PubMedGoogle Scholar
• Keyes LE, Armaza JF, Niermeyer S, et al. Intrauterine growth restriction, preeclampsia and intrauterine mortality at high altitude in Bolivia. Pediatr Res 2003;54:20–5
   PubMed Web of Science ®Google Scholar
• Mikolajczyk RT, Zhang J, Betran AP, et al. A global reference for fetal-weight and birthweight percentiles. Lancet 2011;377:1855–61
   PubMed Web of Science ®Google Scholar
• Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, et al. Uterine artery Doppler and sFlt-1/PLGF ratio: usefulness in diagnosis of pre-eclampsia. Ultrasound Obstet Gynecol 2013;41:530–7
   PubMed Web of Science ®Google Scholar
• Espinoza J, Romero R, Nien JK, et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007;196:326.e1–13
   PubMed Web of Science ®Google Scholar
• Widmer M, Villar J, Benigni A, et al. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol 2007;109:168–80
   PubMed Web of Science ®Google Scholar
• Crispi F, Domínguez C, Llurba E, et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006;195:201–7
   PubMed Web of Science ®Google Scholar
• Myers JE, Kenny LC, McCowan LM, et al. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study. BJOG 2013;120:1215–23
   PubMed Web of Science ®Google Scholar
• Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endogen and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9–23
   PubMed Web of Science ®Google Scholar
• Diguisto C, Le Gouge A, Piver E, et al. Second-trimester uterine artery Doppler, PLGF, sFlt-1, sEndoglin, and lipid-related markers for predicting preeclampsia in a high-risk population. Prenat Diagn 2013;33:1070–4
   PubMed Web of Science ®Google Scholar
• Verlohren S, Herraiz I, Lapaire O, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension 2014;63:346–52
   PubMed Web of Science ®Google Scholar
• Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010;5:173–92
   PubMed Web of Science ®Google Scholar
• Dávila RD, Julian CG, Wilson MJ, et al. Do anti-angiogenic or angiogenic factors contribute to the protection of birth weight at high altitude afforded by Andean ancestry? Reprod Sci 2010;17:861–70
   PubMed Web of Science ®Google Scholar
• Julian CG, Galan HL, Wilson MJ, et al. Lower uterine artery blood flow and higher endothelin relative to nitric oxide metabolite levels are associated with reductions in birth weight at high altitude. Am J Physiol Regul Integr Comp Physiol 2008;295:R906–15
   PubMed Web of Science ®Google Scholar
• Zamudio S, Borges M, Echalar L, et al. Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy. Biol Reprod 2014;90:42
   PubMed Web of Science ®Google Scholar
• Krampl E, Lees C, Bland JM, et al. Fetal Doppler velocimetry at high altitude. Ultrasound Obstet Gynecol 2001;18:329–34
   PubMed Web of Science ®Google Scholar
• Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, et al. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 2012;119:778–87
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011;31:66–74
   PubMed Web of Science ®Google Scholar
• Karagiannis G, Akolekar R, Sarquis R, et al. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther 2011;29:148–54
   PubMed Web of Science ®Google Scholar
• Poon L, Syngelaki A, Akolekar R, et al. Combined screening for preeclampsia and small for gestational age at 11–13 weeks. Fetal Diagn Ther 2013;33:16–27
   PubMed Web of Science ®Google Scholar
• Parra-Cordero M, Rodrigo R, Barja P, et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy. Ultrasound Obstet Gynecol 2013;41:538–44
   PubMed Web of Science ®Google Scholar